US Stock MarketDetailed Quotes
TTOO T2 Biosystems
- 0.5723
- +0.0744+14.94%
Close Nov 29 13:00 ET
- 0.5829
- +0.0106+1.85%
Post 17:02 ET
12.04MMarket Cap-19076P/E (TTM)
0.5800High0.5030Low1.98MVolume0.5190Open0.4979Pre Close1.10MTurnover24.87%Turnover RatioLossP/E (Static)21.04MShares8.379952wk High-1.03P/B4.55MFloat Cap0.415652wk Low--Dividend TTM7.95MShs Float122500.0000Historical High--Div YieldTTM15.47%Amplitude0.4156Historical Low0.5570Avg Price1Lot Size
T2 Biosystems Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 34.85%1.99M | -0.61%1.95M | -0.82%2.06M | -67.75%7.19M | -69.38%1.68M | -59.97%1.47M | -66.77%1.96M | -71.27%2.08M | -20.50%22.31M | -21.45%5.48M |
| Operating revenue | 34.85%1.99M | -0.61%1.95M | -0.82%2.06M | -67.75%7.19M | -69.38%1.68M | -59.97%1.47M | -66.77%1.96M | -71.27%2.08M | -20.50%22.31M | -21.45%5.48M |
| Cost of revenue | 4.48%4.1M | -44.69%2.69M | 5.18%4.2M | -26.88%15.36M | -29.27%2.57M | -35.50%3.93M | -4.17%4.87M | -35.62%4M | 1.48%21.01M | -32.13%3.64M |
| Gross profit | 13.74%-2.12M | 74.49%-741K | -11.68%-2.14M | -730.89%-8.17M | -148.54%-895K | -1.87%-2.45M | -450.00%-2.91M | -286.30%-1.92M | -82.39%1.3M | 13.97%1.84M |
| Operating expense | -6.92%8.05M | -12.93%8.83M | -11.14%10.46M | -30.81%38.98M | -24.87%8.42M | -35.46%8.64M | -35.98%10.15M | -25.91%11.77M | 11.95%56.34M | -5.75%11.21M |
| Selling and administrative expenses | -10.07%5.38M | -13.07%5.47M | -7.69%6.74M | -18.92%24.83M | -19.82%5.26M | -14.78%5.98M | -19.53%6.3M | -20.92%7.3M | 7.35%30.63M | 0.15%6.55M |
| Research and development costs | 0.15%2.67M | -12.70%3.36M | -16.77%3.72M | -44.96%14.15M | -31.98%3.17M | -58.23%2.66M | -52.02%3.85M | -32.83%4.47M | 17.95%25.72M | -12.96%4.66M |
| Operating profit | 8.43%-10.16M | 26.63%-9.58M | 7.94%-12.6M | 14.34%-47.15M | 0.53%-9.32M | 29.77%-11.1M | 13.10%-13.05M | 7.88%-13.69M | -28.09%-55.05M | 8.85%-9.37M |
| Net non-operating interest income expense | 66.93%-370K | 68.98%-478K | 22.54%-1.18M | 12.18%-5.34M | 24.02%-1.16M | 28.27%-1.12M | -14.66%-1.54M | 7.59%-1.52M | 18.71%-6.08M | 17.85%-1.53M |
| Non-operating interest expense | -66.93%370K | -68.98%478K | -22.54%1.18M | -12.18%5.34M | -24.02%1.16M | -28.27%1.12M | 14.49%1.54M | -7.76%1.52M | -19.91%6.08M | -21.80%1.53M |
| Other net income (expense) | 112.90%414K | -86.78%1.09M | 108.89%245K | 376.77%2.42M | -82.46%140K | -21,300.00%-3.21M | 593.42%8.25M | -30,722.22%-2.76M | -171.88%-874K | 16,060.00%798K |
| Gain on sale of security | 153.35%398K | -87.12%1.06M | 96.14%-80K | 811.94%5.43M | -96.36%31K | -1,303.23%-746K | 590.39%8.21M | -18,954.55%-2.07M | -175.45%-762K | 503.32%851K |
| Special income (charges) | --0 | ---- | ---- | -1,562.91%-2.51M | --0 | ---2.51M | ---- | ---- | ---151K | ---151K |
| -Less:Impairment of capital assets | --0 | ---- | ---- | 1,562.91%2.51M | --0 | --2.51M | ---- | ---- | --151K | --151K |
| Other non- operating income (expenses) | -65.96%16K | 3.23%32K | 147.65%325K | -1,369.23%-495K | 11.22%109K | 161.04%47K | 675.00%31K | -34,000.00%-682K | -81.07%39K | --98K |
| Income before tax | 34.41%-10.12M | -41.22%-8.96M | 24.66%-13.53M | 19.23%-50.08M | -2.39%-10.34M | 11.22%-15.43M | 64.81%-6.35M | -8.91%-17.97M | -25.92%-62M | 16.84%-10.1M |
| Income tax | ||||||||||
| Net income | 34.41%-10.12M | -41.22%-8.96M | 24.66%-13.53M | 19.23%-50.08M | -2.39%-10.34M | 11.22%-15.43M | 64.81%-6.35M | -8.91%-17.97M | -25.92%-62M | 16.84%-10.1M |
| Net income continuous Operations | 34.41%-10.12M | -41.22%-8.96M | 24.66%-13.53M | 19.23%-50.08M | -2.39%-10.34M | 11.22%-15.43M | 64.81%-6.35M | -8.91%-17.97M | -25.92%-62M | 16.84%-10.1M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 34.41%-10.12M | -41.22%-8.96M | 24.66%-13.53M | 19.23%-50.08M | -2.39%-10.34M | 11.22%-15.43M | 64.81%-6.35M | -8.91%-17.97M | -25.92%-62M | 16.84%-10.1M |
| Preferred stock dividends | 330K | 0 | ||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 34.41%-10.12M | -41.22%-8.96M | 24.66%-13.53M | 19.66%-50.08M | -2.39%-10.34M | 12.88%-15.43M | 64.81%-6.35M | -8.91%-17.97M | -26.59%-62.33M | 16.84%-10.1M |
| Basic earnings per share | 83.48%-0.57 | 91.84%-0.64 | 97.98%-2.66 | 98.43%-19.19 | 98.19%-2.5478 | 98.83%-3.45 | 98.46%-7.84 | 72.89%-131.77 | 21.15%-1.22K | -1,914.29%-141 |
| Diluted earnings per share | 83.48%-0.57 | 91.84%-0.64 | 97.98%-2.66 | 98.43%-19.19 | 98.19%-2.5478 | 98.83%-3.45 | 98.46%-7.84 | 72.89%-131.77 | 21.15%-1.22K | -1,914.29%-141 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
